Harrow licensed U.S. rights to FDA-approved BYQLOVI for post-surgical eye pain and adds momentum to its branded ophthalmic ...

William Blair initiated coverage of Coinbase Global (NASDAQ:COIN) with an Outperform rating, calling the crypto exchange the best-positioned company to capitalize on what it sees as a transformative ...

Fintel reports that on June 11, 2025, William Blair initiated coverage of Coinbase Global (NasdaqGS:COIN) with a Outperform recommendation. Analyst Price Forecast Suggests 8.01% Upside As of June 2, ...

However, some famous restaurant chains fared much worse. At McDonald’s, only 60 percent of workers said they’d recommend ...

Among the nation’s major restaurant chains, In-N-Out is still supreme when it comes to the satisfaction of its workers, ...

The number of such cards the buy now, pay later provider has now made available is an increase of about 600,000 cards since ...

Chime, a leading consumer financial technology company, today announced the pricing of its initial public offering of 32,000,000 shares of its Class A common stock at a ...

Crispr Therapeutics' current revenue from CASGEVY is limited by high costs, profit-sharing, and logistical hurdles. Click ...

Analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Skye Bioscience in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska ...

Nkarta (NASDAQ:NKTX – Get Free Report) had its price target lowered by research analysts at Mizuho from $16.00 to $14.00 in a ...

Questions remain as to how FDA inspection differences between domestic and foreign drug facilities will play out.